Emergent Health Corp (EM)【EMGE】株式ニュース

hear your frustration, and it’s completely understandable given the situation with EMGE shareholders feeling sidelined over a year after the merger with KOAN, especially with assets like Evolutionary Biologics (Evobio) now under KOAN’s umbrella. As of 12:56 PM PDT on Thursday, June 19, 2025, let’s assess whether seeking legal representation might be warranted and how to approach this.
Current Context: The Share Exchange Agreement (closed March 14, 2024) transferred EMGE’s assets, including Evobio
and Juventix, to KOAN (now Apollo Biowellness). EMGE shareholders were supposed to receive KOAN shares, but many, like you, report not seeing this conversion, leaving you with potentially worthless EMGE stock. LB Equity Advisors’ post on June 18, 2025, about an upcoming press release suggests updates on the merger and acquisitions, but it’s unclear if it addresses EMGE shareholders’ grievances. You invested based on Evobio’s potential, and its reassignment to KOAN without apparent benefit to EMGE holders could feel like a bait-and-switch.
Signs of Potential Foul Play: If the merger terms (e.g., share exchange without dilution, as per InvestorsHub) haven’t been honored, this could breach fiduciary duty or securities laws. Over 15 months without share conversion or clear communication might violate SEC disclosure requirements for OTC Pink stocks, especially if shareholders were misled. If Evobio’s value was a key draw and its transfer to KOAN diluted EMGE shareholders’ stakes without compensation, this could suggest mismanagement or self-dealing by insiders. With KOAN still trading as a penny stock ($0.01-$0.10 range) and no significant price movement post-merger, the deal’s benefits may not have trickled down.
Should You Seek Legal Representation? Consider it if there’s a breach of contract (if the merger agreement promised specific share exchanges or protections that haven’t materialized), securities fraud (if LB Equity Advisors or insiders misrepresented the merger’s benefits), or class action potential (if many EMGE shareholders are affected). The press release (due soon) might resolve this—give it until June 23 to see. But if your investment is small, legal costs (often $10,000+ upfront) might outweigh recovery unless part of a class action. For securities fraud, you have 2-3 years from discovery (potentially mid-2024), so acting soon preserves options. Hold off if the press release satisfies, or if evidence of intentional deceit is lacking.
Steps Before Legal Action: Contact LB Equity Advisors via their post and ask, “As an EMGE shareholder who invested due to Evolutionary Biologics, can you confirm the timeline for converting my shares to KOAN stock, given the merger closed 15+ months ago? Will there be compensation for the delay?” and “Is EMGE still a subsidiary, and how are original shareholders benefiting from assets like Evobio now under KOAN?” Check your brokerage statements and the merger 8-K (on otcmarkets.com under EMGE or KOAN filings) to confirm your entitled shares. Post here on InvestorsHub to see if others share your experience—a collective voice might pressure the company or attract a class-action attorney. If the press release fails, consult a securities attorney (e.g., The Rosen Law Firm) for a free eval, asking if the delay and asset transfer suggest a breach or fraud, and what evidence to gather.
Risks and Realities: Penny stock cases often yield low recoveries (e.g., $0.01-$0.10 per share) unless fraud is proven, and legal fees could erase gains. If LB Equity Advisors or KOAN’s management stonewalls, it might signal deeper issues. Recent tariff threats (e.g., U.S. on Canadian goods, June 2025) could impact KOAN’s acquisition plans, but not shareholder neglect.
My Take: You’re justified in feeling “fucked over” if Evobio drove your investment and you’re still holding valueless EMGE shares. Wait until after the press release (by June 23) to see if it addresses share conversion and compensation. If it’s a non-answer, consult a securities attorney for a quick eval—especially if others join you. Gather your investment docs now. Legal action is a last resort but viable if evidence points to intentional harm.
What do you think—wait for the update or start drafting that inquiry to LB Equity Advisors? I can help word it if you’d like!
Disclaimer: I’m not a lawyer; please consult one. Don’t share info that can identify you.
There you go—clean text ready to paste! Let me know if you want help crafting that inquiry or anything else. Good luck on InvestorsHub!

PS. Isn't the dumb Fuck Zimmerman whatever his name is in Probation Already amd the pice of.chit doesn't even mention $Emge in the recent koan news while shit heads are Pumping it maybe to pay his salary
...